(Q43065085)

13 November 2017

0 references

Trastuzumab in the adjuvant setting: concurrent or sequential? It takes two to tango! (English)

1 reference

13 November 2017

1 reference

Sunil Verma

1

1 reference

13 November 2017

1 January 2008

1 reference

13 November 2017

1 reference

13 November 2017

15

1 reference

13 November 2017

1

1 reference

13 November 2017

66-67

1 reference

Creative Commons Attribution 4.0 International

13 November 2017

start time

1 January 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259429

PubMed Central

reference URL

Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259429

PubMed Central

reference URL

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259429

PubMed Central

reference URL

15 August 2018

Identifiers

DOI

10.3747/CO.2008.204

1 reference

13 November 2017

1 reference

PMC publication ID

2259429

13 November 2017

PubMed publication ID

18317588

1 reference

PMC publication ID

2259429